RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Crijns, Harry J G M ^a   Bash, Lori D ^b   Chazelle, François ^c   Le Heuzey, Jean Yves ^d   Lewalter, Thorsten ^e   Lip, Gregory Y H ^f   Maggioni, Aldo P ^g   Martín, Alfonso ^h   Ponikowski, Piotr ⁱ   Rosenqvist, Mårten ^j   Sanders, Prashanthan ^k   Scanavacca, Mauricio ^l   Bernhardt, Alexandra A ^m   Unniachan, Sreevalsa ⁿ   Phatak, Hemant M ^b   Gitt, Anselm K ^m  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Dohme Chibret Centre de Recherche Riom   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITY OF BONN   (Germany)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g ANMCO RESEARCH CENTER   (Italy)

^h HOSPITAL SEVERO OCHOA   (Spain)

ⁱ WROCLAW MEDICAL UNIVERSITY   (Poland)

^j KAROLINSKA INSTITUTE   (Sweden)

^k UNIVERSITY OF ADELAIDE   (Australia)

^l UNIVERSITY OF SÃO PAULO   (Brazil)

^m Institut fur Herzinfarktforschung Ludwigshafen   (Germany)

ⁿ RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Atrial fibrillation; Cardioversion; Heart failure; Registry; Stroke

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DRONEDARONE; FLECAINIDE; PROPAFENONE; SOTALOL; VERAPAMIL;

ARTICLE; CARDIOVERSION; COST EFFECTIVENESS ANALYSIS; DISEASE REGISTRY; HEALTH CENTER; HEART ATRIUM FIBRILLATION; HOSPITAL BED CAPACITY; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STUDY DESIGN; TEACHING HOSPITAL; TREATMENT OUTCOME;

AMIODARONE; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; HUMANS; PROSPECTIVE STUDIES; REGISTRIES;

EID: 84866780743     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-85     Document Type: Article

References (21)

1. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006, 27:949-953.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the ATRIA study. JAMA 2001, 285:2370-2375. 10.1001/jama.285.18.2370, 11343485.
3. DeWilde S, Carey IM, Emmas C, Richards N, Cook DG. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 2006, 92(8):1064-1070. 10.1136/hrt.2005.069492, 1861124, 16387813.
4. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 2011, 13:1110-1117. 10.1093/europace/eur132, 21551478.
5. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009, 104:1534-1539. 10.1016/j.amjcard.2009.07.022, 19932788.
6. Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005, 45:705-711. 10.1016/j.jacc.2004.06.080, 15734614.
7. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Seward JB, Iwasaka T, Tsang TS. Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med 2007, 120:357-363. 10.1016/j.amjmed.2006.06.042, 17398231.
8. Sanoski CA. Clinical, economic, and quality of life impact of atrial fibrillation. J Manag Care Pharm 2009, 15(6 Suppl B):S4-S9.
9. Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P, . ATRIUM investigators Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol 2011, 100(10):897-905. 10.1007/s00392-011-0320-5, 3178025, 21533828, ATRIUM investigators.
10. Wong CX, Brooks AG, Leong DP, Roberts-Thomson KC, Sanders P. The increasing burden of atrial fibrillation compared to heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. Arch Intern Med 2012, 172(9):739-741. 10.1001/archinternmed.2012.878, 22782205.
11. Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC, . RACE Study Group Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 2004, 43(2):241-247. 10.1016/j.jacc.2003.08.037, 14736444, RACE Study Group.
12. Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. JAMA 1962, 182:548-555.
13. Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, Tieleman RG, Crijns HJ. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol 1999, 84(9A):147R-151R.
14. Gallagher MM, Yap YG, Padula M, Ward DE, Rowland E, Camm AJ. Arrhythmic complications of electrical cardioversion: relationship to shock energy. Int J Cardiol 2008, 123(3):307-312. 10.1016/j.ijcard.2006.12.014, 17395302.
15. Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G. Outpatient treatment of recent-onset atrial fibrillation with the " pill-in-the-pocket" approach. N Engl J Med 2004, 351(23):2384-2391. 10.1056/NEJMoa041233, 15575054.
16. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, . Association European Heart Rhythm European Association for Cardio-Thoracic Surgery Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31(19):2369-2429. Association European Heart Rhythm European Association for Cardio-Thoracic Surgery.
17. Pisters R, Nieuwlaat R, Prins MH, Le Heuzey JY, Maggioni AP, Camm AJ, Crijns HJ. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace 2012, 14:666-674. Epub ahead of print, 10.1093/europace/eur406, 22223715.
18. Tieleman RG, Gosselink AT, Crijns HJ, van Gelder IC, van den Berg MP, de Kam PJ, van Gilst WH, Lie KI. Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol 1997, 79:53-57. 10.1016/S0002-9149(96)00675-3, 9024736.
19. Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Raisch DW, Ezekowitz MD, . Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005, 352:1861-1872. 10.1056/NEJMoa041705, 15872201, Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators.
20. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP, . RACE II Investigators Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010, 362(15):1363-1373. 10.1056/NEJMoa1001337, 20231232, RACE II Investigators.
21. Hendriks JML, De Wit R, Crijns HJGM, Vrijhoef HJM, Prins MH, Pisters R, Pison LAFG, Blaauw Y, Tieleman RG. Nurse-Led care versus usual care for patients with atrial fibrillation. Results of a randomized trial of integrated chronic care versus routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J 2012, in press.